Update on immunomodulatory drugs (IMiDs) in hematologic and solid malignancies

By Vallet Sonia   Witzens-Harig Mathias   Jaeger Dirk   Podar Klaus  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. : 473-494

Informa Healthcare

Access to resources Recommend Favorite

Immunomodulatory Drugs (IMiDs) in Multiple Myeloma

By  

Current Cancer Drug Targets, Vol. 17, Iss. 9, 2017-10 ,pp. : 846-857

Bentham Science Publishers

Access to resources Recommend Favorite

Immunomodulatory Drugs (IMiDs™): A New Treatment Option for Myelodysplastic Syndromes

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 5, 2006-10 ,pp. : 339-342

Bentham Science Publishers

Access to resources Recommend Favorite

Thalidomide Derived Immunomodulatory Drugs (IMiDs) as Potential Therapeutic Agents

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 3, 2003-09 ,pp. : 181-186

Bentham Science Publishers

Access to resources Recommend Favorite

Entinostat for treatment of solid tumors and hematologic malignancies

By Knipstein Jeffrey   Gore Lia  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1455-1467

Informa Healthcare

Access to resources Recommend Favorite